181 related articles for article (PubMed ID: 32586423)
21. Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.
Sharon C; Baranwal S; Patel NJ; Rodriguez-Agudo D; Pandak WM; Majumdar AP; Krystal G; Patel BB
Oncotarget; 2015 Jun; 6(17):15332-47. PubMed ID: 25895029
[TBL] [Abstract][Full Text] [Related]
22. AKT down-regulates insulin-like growth factor-1 receptor as a negative feedback.
Qin L; Wang Y; Tao L; Wang Z
J Biochem; 2011 Aug; 150(2):151-6. PubMed ID: 21616916
[TBL] [Abstract][Full Text] [Related]
23. Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.
Yoo SM; Lee CJ; Kang HC; Lee HS; Lee JY; Kim KD; Kim DJ; An HJ; Cho YY
Mol Carcinog; 2019 Jul; 58(7):1221-1233. PubMed ID: 30887599
[TBL] [Abstract][Full Text] [Related]
24. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
25. Growth signaling and longevity in mouse models.
Kim SS; Lee CK
BMB Rep; 2019 Jan; 52(1):70-85. PubMed ID: 30545442
[TBL] [Abstract][Full Text] [Related]
26. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways.
Kenessey A; Ojamaa K
J Biol Chem; 2006 Jul; 281(30):20666-20672. PubMed ID: 16717100
[TBL] [Abstract][Full Text] [Related]
27. The mammalian target of rapamycin-p70 ribosomal S6 kinase but not phosphatidylinositol 3-kinase-Akt signaling is responsible for fibroblast growth factor-9-induced cell proliferation.
Wing LY; Chen HM; Chuang PC; Wu MH; Tsai SJ
J Biol Chem; 2005 May; 280(20):19937-47. PubMed ID: 15760907
[TBL] [Abstract][Full Text] [Related]
28. Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway.
Sandri M; Barberi L; Bijlsma AY; Blaauw B; Dyar KA; Milan G; Mammucari C; Meskers CG; Pallafacchina G; Paoli A; Pion D; Roceri M; Romanello V; Serrano AL; Toniolo L; Larsson L; Maier AB; Muñoz-Cánoves P; Musarò A; Pende M; Reggiani C; Rizzuto R; Schiaffino S
Biogerontology; 2013 Jun; 14(3):303-23. PubMed ID: 23686362
[TBL] [Abstract][Full Text] [Related]
29. The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway.
Park S; Lim S; Chang W; Song H; Lee S; Song BW; Kim HJ; Cha MJ; Choi E; Jang Y; Chung N; Cho SY; Hwang KC
Yonsei Med J; 2008 Aug; 49(4):592-600. PubMed ID: 18729301
[TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
31. PI3K-p110-alpha-subtype signalling mediates survival, proliferation and neurogenesis of cortical progenitor cells via activation of mTORC2.
Wahane SD; Hellbach N; Prentzell MT; Weise SC; Vezzali R; Kreutz C; Timmer J; Krieglstein K; Thedieck K; Vogel T
J Neurochem; 2014 Jul; 130(2):255-67. PubMed ID: 24645666
[TBL] [Abstract][Full Text] [Related]
32. The Effects of Exogenous Lactate Administration on the IGF1/Akt/mTOR Pathway in Rat Skeletal Muscle.
Kyun S; Yoo C; Park HY; Kim J; Lim K
Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33113811
[TBL] [Abstract][Full Text] [Related]
33. Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
Sharma S; Guthrie PH; Chan SS; Haq S; Taegtmeyer H
Cardiovasc Res; 2007 Oct; 76(1):71-80. PubMed ID: 17553476
[TBL] [Abstract][Full Text] [Related]
34. Ghrelin promotes human non-small cell lung cancer A549 cell proliferation through PI3K/Akt/mTOR/P70S6K and ERK signaling pathways.
Zhu J; Yao J; Huang R; Wang Y; Jia M; Huang Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):616-620. PubMed ID: 29524402
[TBL] [Abstract][Full Text] [Related]
35. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
[TBL] [Abstract][Full Text] [Related]
37. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.
Lee JE; Lim MS; Park JH; Park CH; Koh HC
Mol Neurobiol; 2016 Aug; 53(6):3771-3782. PubMed ID: 26143260
[TBL] [Abstract][Full Text] [Related]
38. Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.
Shi Y; Hsu JH; Hu L; Gera J; Lichtenstein A
J Biol Chem; 2002 May; 277(18):15712-20. PubMed ID: 11872747
[TBL] [Abstract][Full Text] [Related]
39. PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.
Akundi RS; Zhi L; Büeler H
Neurobiol Dis; 2012 Jan; 45(1):469-78. PubMed ID: 21945539
[TBL] [Abstract][Full Text] [Related]
40. Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.
Kitakaze T; Yoshikawa M; Kobayashi Y; Kimura N; Goshima N; Ishikawa T; Ogata Y; Yamashita Y; Ashida H; Harada N; Yamaji R
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118563. PubMed ID: 31666191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
